An integrated mass-spectrometry pipeline identifies novel protein coding-regions in the human genome

28Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Background: Most protein mass spectrometry (MS) experiments rely on searches against a database of known or predicted proteins, limiting their ability as a gene discovery tool. Results: Using a search against an in silico translation of the entire human genome, combined with a series of annotation filters, we identified 346 putative novel peptides [False Discovery Rate (FDR),5%] in a MS dataset derived from two human breast epithelial cell lines. A subset of these were then successfully validated by a different MS technique. Two of these correspond to novel isoforms of Heterogeneous Ribonuclear Proteins, while the rest correspond to novel loci. Conclusions: MS technology can be used for ab initio gene discovery in human data, which, since it is based on different underlying assumptions, identifies protein-coding genes not found by other techniques. As MS technology continues to evolve, such approaches will become increasingly powerful. Copyright: © 2010 Bitton et al.

Cite

CITATION STYLE

APA

Bitton, D. A., Smith, D. L., Connolly, Y., Scutt, P. J., & Miller, C. J. (2010). An integrated mass-spectrometry pipeline identifies novel protein coding-regions in the human genome. PLoS ONE, 5(1). https://doi.org/10.1371/journal.pone.0008949

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free